Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Gerson

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Hematology/Oncology Clinics of North America|April 1, 1995
O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistanceS L Gerson, J K Willson
Blood|April 1, 1984
Release of granulocyte-specific colony-stimulating activity by human bone marrow exposed to phorbol estersS L Gerson, R A Cooper
Leukemia Research|January 1, 1984
Myelopoiesis following phorbol ester exposure in human long-term bone marrow cell cultureS L Gerson, R A Cooper
Seminars in Oncology|February 1, 1996
Introduction: genes, oncogenes, and gene therapy strategies for cancerE C Lattime, S L Gerson
Seminars in Oncology|December 1, 1989
Hematopoietic emergenciesS L Gerson, H M Lazarus
Cancer Research|April 15, 1989
The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytesJ E Trey, S L Gerson
Cancer Chemotherapy and Pharmacology|August 14, 1999
Acquired resistance to O6-benzylguanine plus chloroethylnitrosoureas in human breast cancerW P Phillips, S L Gerson
Blood|May 1, 1988
Modulation of nitrosourea resistance in myeloid leukemiasS L Gerson, J E Trey
Oncogene|August 10, 1999
Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMTX Qin, L Liu, S L Gerson
Carcinogenesis|April 7, 2000
Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosoureaX Qin, D Shibata, S L Gerson
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Hematology/Oncology Clinics of North America|April 1, 1995
O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistanceS L Gerson, J K Willson
Blood|April 1, 1984
Release of granulocyte-specific colony-stimulating activity by human bone marrow exposed to phorbol estersS L Gerson, R A Cooper
Leukemia Research|January 1, 1984
Myelopoiesis following phorbol ester exposure in human long-term bone marrow cell cultureS L Gerson, R A Cooper
Seminars in Oncology|February 1, 1996
Introduction: genes, oncogenes, and gene therapy strategies for cancerE C Lattime, S L Gerson
Seminars in Oncology|December 1, 1989
Hematopoietic emergenciesS L Gerson, H M Lazarus
Cancer Research|April 15, 1989
The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytesJ E Trey, S L Gerson
Cancer Chemotherapy and Pharmacology|August 14, 1999
Acquired resistance to O6-benzylguanine plus chloroethylnitrosoureas in human breast cancerW P Phillips, S L Gerson
Blood|May 1, 1988
Modulation of nitrosourea resistance in myeloid leukemiasS L Gerson, J E Trey
Oncogene|August 10, 1999
Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMTX Qin, L Liu, S L Gerson
Carcinogenesis|April 7, 2000
Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosoureaX Qin, D Shibata, S L Gerson
Pageof 15